(COR) - Analyzing Cencora's Short Interest
Cencora's (NYSE:COR) short percent of float has risen 7.85% since its last report. The company recently reported that it has 9.40 million shares sold short, which is 6.46% of all regular shares that a
These 4 Measures Indicate That Cencora (NYSE:COR) Is Using Debt Reasonably Well
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a very important factor, when
Earnings Scorecard: Nike Loses Air After Shocker Results Send Shares Sliding
BofA Securities Maintains Cencora(COR.US) With Buy Rating, Maintains Target Price $256
BofA Securities analyst Allen Lutz maintains $Cencora(COR.US)$ with a buy rating, and maintains the target price at $256.According to TipRanks data, the analyst has a success rate of 54.2% and a total
Cencora Shares Are Trading Lower After Walgreens Lowered Its Outlook and Announced Store Closure.
Cencora Shares Are Trading Lower After Walgreens Lowered Its Outlook and Announced Store Closure.
Leerink Partners Maintains Outperform on Cencora, Maintains $275 Price Target
Leerink Partners analyst Michael Cherny maintains Cencora (NYSE:COR) with a Outperform and maintains $275 price target.
Cencora Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/27/2024 20.7% Leerink Partners $275 → $275 Maintains Outperform 05/02/2024 21.58% Baird $275 → $277 Mai
CVS, Cencora Drop as Walgreens Announces Store Closures
Cencora on Pace for Largest Percent Decrease Since May 2022 -- Data Talk
Cencora, Inc. (COR) is currently at $224.55, down $12.73 or 5.36% --Would be lowest close since May 30, 2024, when it closed at $220.53 --On pace for largest percent decrease since May 12, 2022, whe
Leerink Partners Maintains Cencora(COR.US) With Buy Rating, Maintains Target Price $275
Leerink Partners analyst Michael Cherny maintains $Cencora(COR.US)$ with a buy rating, and maintains the target price at $275.According to TipRanks data, the analyst has a success rate of 49.8% and a
Cencora Stock: Is COR Outperforming the Healthcare Sector?
Stocks With the Highest ROIC but Not the Highest Valuation - Bernstein SG
Cencora(COR.US) Officer Sells US$2.54 Million in Common Stock
$Cencora(COR.US)$ Officer COLLIS STEVEN H sold 10,754 shares of common stock on Jun 18, 2024 at an average price of $235.76 for a total value of $2.54 million.Source: Announcement What is statement of
Here's How Much You Would Have Made Owning Cencora Stock In The Last 5 Years
Cencora (NYSE:COR) has outperformed the market over the past 5 years by 9.87% on an annualized basis producing an average annual return of 23.14%. Currently, Cencora has a market capitalization of $46
Form 144 | Cencora(COR.US) Officer Proposes to Sell 2.54 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 18, $AmerisourceBergen(ABC.US)$、$Cencora(COR.US)$ Officer COLLIS STEVEN H intends to sell 10,754 shares of its common stock on Jun 18, with a total market value of approxim
Cencora (COR) Gains 13.2% YTD: What's Driving the Stock?
Argus Research Maintains Cencora(COR.US) With Buy Rating, Maintains Target Price $270
Argus Research analyst David Toung maintains $Cencora(COR.US)$ with a buy rating, and maintains the target price at $270.According to TipRanks data, the analyst has a success rate of 63.2% and a total
Are Investors Undervaluing Cencora, Inc. (NYSE:COR) By 42%?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Cencora fair value estimate is US$400 Current share price of US$232 suggests Cencora is potentially 42% undervalued The US$256 analyst pri
Morgan Stanley Maintains Cencora(COR.US) With Hold Rating, Raises Target Price to $229
Morgan Stanley analyst Erin Wright maintains $Cencora(COR.US)$ with a hold rating, and adjusts the target price from $190 to $229.According to TipRanks data, the analyst has a success rate of 65.6% an
Express News | NYSE Order Imbalance 91120.0 Shares on Sell Side